Literature DB >> 8409320

Fulminant hepatic failure with massive necrosis as a result of hepatitis A infection.

C T Masada1, B W Shaw, R K Zetterman, S S Kaufman, R S Markin.   

Abstract

Fulminant hepatic failure as a result of hepatitis A is a rarely diagnosed complication entity in developed countries. With the advent of specific serologic markers for acute hepatitis A virus infection, the incidence and pathology of fulminant hepatitis A can be more clearly defined. We describe four patients (one adult, three children; two males and two females, ages 2 1/2-58 years) referred to our institution for orthotopic liver transplantation subsequent to fulminant hepatic failure following hepatitis A infection. All of these patients had a history of residence in or travel to hepatitis A endemic areas. Hepatitis A infection was documented by the presence of serum IgM against hepatitis A virus prior to transplantation. Infection with hepatitis B virus, cytomegalovirus, Epstein-Barr virus, and herpes simplex virus was excluded by clinical and specific serologic examinations. All patients presented with varying degrees of encephalopathy, progressing to coma. Coagulopathy in the form of prolonged prothrombin time and partial thromboplastin time was present in all patients. Peak liver parenchymal enzymes increased to greater than ten times the upper limit of the normal range. Total and direct bilirubin levels increased to > 20 and 10 mg/dl, respectively. Histologic evaluation of the explanted livers showed a spectrum of changes ranging from periportal hepatocellular necrosis with focal parenchymal collapse and prominent bile duct proliferation to massive necrosis with complete loss of hepatic architecture.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8409320     DOI: 10.1097/00004836-199309000-00014

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  2 in total

1.  Assessing the eligibility for liver transplantation of patients with fulminant hepatitis.

Authors:  S Uetsuji; H Komada; A H Kwon; Y Kamiyama; Y Uedono; T Tanaka
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes.

Authors:  Ryan M Taylor; Timothy Davern; Santiago Munoz; Stephen-Huy Han; Brendan McGuire; Anne M Larson; Linda Hynan; William M Lee; Robert J Fontana
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.